Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Weight Loss Treatment
    • 1.2.1.2 Insulin-Sensitizing Agents
    • 1.2.1.3 Lipid-Lowering Drugs
    • 1.2.1.4 Antioxidants
    • 1.2.1.5 Others
  • 1.2.2 by Application
    • 1.2.2.1 Hospitals
    • 1.2.2.2 Clinics
    • 1.2.2.3 Research Institute
    • 1.2.2.4 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Weight Loss Treatment Market, 2013-2018
  • 4.1.2 Insulin-Sensitizing Agents Market, 2013-2018
  • 4.1.3 Lipid-Lowering Drugs Market, 2013-2018
  • 4.1.4 Antioxidants Market, 2013-2018
  • 4.1.5 Others Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Weight Loss Treatment Market Forecast, 2019-2024
  • 4.2.2 Insulin-Sensitizing Agents Market Forecast, 2019-2024
  • 4.2.3 Lipid-Lowering Drugs Market Forecast, 2019-2024
  • 4.2.4 Antioxidants Market Forecast, 2019-2024
  • 4.2.5 Others Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Hospitals Market, 2013-2018
  • 5.1.2 Clinics Market, 2013-2018
  • 5.1.3 Research Institute Market, 2013-2018
  • 5.1.4 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Hospitals Market Forecast, 2019-2024
  • 5.2.2 Clinics Market Forecast, 2019-2024
  • 5.2.3 Research Institute Market Forecast, 2019-2024
  • 5.2.4 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Boehringer Ingelheim
• 8.2 Cerenis Therapeutics
• 8.3 Connexios Life Sciences
• 8.4 Genfit
• 8.5 Islet Sciences
• 8.6 Nimbus Therapeutics
• 8.7 Verva Pharmaceuticals
• 8.8 Viking Therapeutics
• 8.9 Astazeneca Plc
• 8.10 Galmed Pharmaceuticals
• 8.11 GENFIT SA
• 8.12 Gilead Science
• 8.13 Novo Nordisk
• 8.14 Immuron
• 8.15 Intercepts Pharmaceuticals
• 8.16 Enzo Biochem
• 8.17 Tobira Therapeutics

9 Conclusion

Summary
The global Nonalcoholic Steatohepatitis (NASH) market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Weight Loss Treatment
Insulin-Sensitizing Agents
Lipid-Lowering Drugs
Antioxidants
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Boehringer Ingelheim
Cerenis Therapeutics
Connexios Life Sciences
Genfit
Islet Sciences
Nimbus Therapeutics
Verva Pharmaceuticals
Viking Therapeutics
Astazeneca Plc
Galmed Pharmaceuticals
GENFIT SA
Gilead Science
Novo Nordisk
Immuron
Intercepts Pharmaceuticals
Enzo Biochem
Tobira Therapeutics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Clinics
Research Institute
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa